//
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"